Ajay Vaidya (@ajay_vaidya) 's Twitter Profile
Ajay Vaidya

@ajay_vaidya

HF/Transplant Cardiologist | Northwestern '07 | Tufts Med MD/MPH '11 | UCSF IM '14 | Mt. Sinai Cards '17 | Cedars Sinai HF/HT '18 | Asst Prof of Med @keckmedusc

ID: 279238890

calendar_today08-04-2011 21:39:14

39 Tweet

155 Followers

187 Following

Ajay Vaidya (@ajay_vaidya) 's Twitter Profile Photo

โ€œThe screams of disrespected voices are ringing out in our nation right now. We must never condone violent riots that take lives and destroy futures but we must also hear the desperate voice of protest that is calling out for justice.โ€ nytimes.com/2020/06/07/spoโ€ฆ

Barack Obama (@barackobama) 's Twitter Profile Photo

Today reminds us that progress might be slow. It might take decades. But no matter what things might look like today, itโ€™s always possible. Happy Pride month, everybody.

Today reminds us that progress might be slow. It might take decades. But no matter what things might look like today, itโ€™s always possible. Happy Pride month, everybody.
Mark Drazner (@markdrazner) 's Twitter Profile Photo

HFSAP product now live; collaborative effort between American College of Cardiology and HFSA. Thanks to the star contributors in bringing this to fruition. A tremendous privilege working with my Co-Editor-in-Chief Michelle Kittleson MD PhD! BiykemBozkurt Randall Starling James Fang acc.org/Hfsap

Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

Combined Heart-Kidney Transplant Versus Sequential Kidney Transplant in Heart Transplant Recipients: Patients with eGFR<30 or in dialysis presented better survival with HKTx, while both SKTx and HKTx are suitable for patients with eGFR between 30 and 45. onlinejcf.com/article/S1071-โ€ฆ

Combined Heart-Kidney Transplant Versus Sequential Kidney Transplant in Heart Transplant Recipients: Patients with eGFR&lt;30 or in dialysis presented better survival with HKTx, while both SKTx and HKTx are suitable for patients with eGFR between 30 and 45. onlinejcf.com/article/S1071-โ€ฆ
Ajay Vaidya (@ajay_vaidya) 's Twitter Profile Photo

Kittleson rules go through my head every day (whether I like it or not ๐Ÿ˜‰). Truly best job...and mentor/fellowship director...ever.

Ajay Vaidya (@ajay_vaidya) 's Twitter Profile Photo

Agreed, congrats Nora! She truly is an icon. She is such a caring and impactful teacher, and excellent clinician - and she always does it in style with her heels! Still remember my many lessons from her

LAC+USC Cardiovascular Medicine Fellowship (@usc_cardiology) 's Twitter Profile Photo

We're very excited to meet our candidates for the upcoming cardiology fellowship interview cycle. Check out this great webinar hosted by American College of Cardiology for some useful tips/tricks to nail your virtual cardiology fellowship interviews! #ACCFIT #Cardiology #fellowship #MedTwitter

LAC+USC Cardiovascular Medicine Fellowship (@usc_cardiology) 's Twitter Profile Photo

A huge congratulations ๐ŸŽ‰๐ŸŽŠ and warm welcome to the 2024 USC Cardiovascular Medicine ๐Ÿซ€๐Ÿฅผ๐Ÿฉบfellowship class! We are so excited for you and canโ€™t wait to work with you all!! ๐Ÿฅณ๐Ÿฅณ๐Ÿฅณ

A huge congratulations ๐ŸŽ‰๐ŸŽŠ and warm welcome to the 2024 USC Cardiovascular Medicine ๐Ÿซ€๐Ÿฅผ๐Ÿฉบfellowship class! We are so excited for you and canโ€™t wait to work with you all!! ๐Ÿฅณ๐Ÿฅณ๐Ÿฅณ
TCC Community of Practice (TCC COP) - AST (@tcccop) 's Twitter Profile Photo

โšก๏ธTCC โ€“COP SPOTLIGHT โšก๏ธ #Interviewwithamentor Dr. Jon Kobashigawa, Director of the Heart Transplant Program at the Cedars-Sinai Heart Institute and member of the TCC COP Want to know how Dr. Kobashigawa become a leader in the heart transplant field? Check our Hub ๐Ÿ‘‡

โšก๏ธTCC โ€“COP SPOTLIGHT โšก๏ธ
#Interviewwithamentor

Dr. Jon Kobashigawa, Director of the Heart Transplant Program at the Cedars-Sinai Heart Institute and member of the TCC COP

Want to know how Dr. Kobashigawa become a leader in the heart transplant field? Check our Hub ๐Ÿ‘‡
USCHeartFailure (@uscheartfailure) 's Twitter Profile Photo

In honor of the end of #HeartMonth, we want to highlight our @KeckMedUSC USCHeartFailure LVAD recipient selected as part of American Heart Association #RealWomen2022. Dr Raymond C Lee MD Ajay Vaidya Aaron Wolfson Kori Yoni Nattiv Check out her amazing story: goredforwomen.org/en/about-heartโ€ฆ

Aaron Wolfson (@wolfsonaaron) 's Twitter Profile Photo

With the UNOS policy change, do improvements in waitlist outcomes for patients awaiting HTx in the hospital come at the expense of those waiting at home? Nope. While hospitalized patients see the greatest gains, those waiting at home are not harmed and may have marginal benefit.

With the UNOS policy change, do improvements in waitlist outcomes for patients awaiting HTx in the hospital come at the expense of those waiting at home? Nope. While hospitalized patients see the greatest gains, those waiting at home are not harmed and may have marginal benefit.
JHLT (@thejhlt) 's Twitter Profile Photo

Following the 2018 UNOS policy change, the rates of #HTx for higher acuity patients increased while the risk of rejection and treated rejection decreased over time without impacting the risk of hospitalization for rejection and infection. Ajay Vaidya ๐Ÿ”—: jhltonline.org/article/S1053-โ€ฆ

JHLT (@thejhlt) 's Twitter Profile Photo

No added waitlist benefits for heart-kidney candidates following policy change and post-policy change one-year survival has worsened for heart-kidney recipients. Aaron Wolfson ๐Ÿ”—jhltonline.org/article/S1053-โ€ฆ

No added waitlist benefits for heart-kidney candidates following policy change and post-policy change one-year survival has worsened for heart-kidney recipients. <a href="/wolfsonaaron/">Aaron Wolfson</a>

๐Ÿ”—jhltonline.org/article/S1053-โ€ฆ
Keck Medicine of USC (@keckmedicineusc) 's Twitter Profile Photo

โ€œIf someone has end-stage heart failure or cardiomyopathy and has exhausted treatment options, they might be a candidate for a heart transplant,โ€ says Dr. Ajay S. Vaidya. ๐Ÿ’“ Hereโ€™s how to get on the list โคต๏ธ bit.ly/44zT1Wi #DonateLifeMonth